RSV vaccine study tests multidose vial safety

NCT ID NCT06473519

First seen Nov 01, 2025 · Last updated Jun 17, 2026 · Updated 34 times

Summary

This study tested an RSV vaccine in 453 healthy women aged 18-49. It compared a multidose vial with a preservative to a single-dose vial without one. The goal was to see if both versions are safe and produce a similar immune response. Participants received one shot and were followed for about 6 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS (RSV) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Clinical Research Atlanta

    Stockbridge, Georgia, 30281, United States

  • Clinical Research Prime

    Idaho Falls, Idaho, 83404, United States

  • Clinical Research Prime Rexburg

    Rexburg, Idaho, 83440, United States

  • Clinical Trials of Texas, LLC dba Flourish Research

    San Antonio, Texas, 78229, United States

  • Headlands Research - Detroit

    Southfield, Michigan, 48034, United States

  • Qps-Mra, Llc

    South Miami, Florida, 33143, United States

Conditions

The condition(s) this trial relates to.

respiratory syncytial virus infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.